Semaglutide for HIV and alcohol use
Treatments studied
Part of Mental health clinical trials.
This study is testing whether semaglutide, a medication already used for diabetes and weight loss, can help people with HIV who also have an alcohol use disorder cut back on drinking. It is for patients treated at the Atlanta VA Healthcare System.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are diagnosed with HIV and get your care at the Atlanta VA Healthcare System.
- You are 18 years or older.
- You have mild, moderate, or severe alcohol use disorder.
- You have evidence of recent heavy drinking (blood test showing PEth >20 ng/mL).
- You are currently taking 5 or more medications.
- You are not currently in treatment or taking medication specifically for alcohol use disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a medication called semaglutide (used for diabetes and weight loss) can help reduce alcohol craving and drinking. It also looks at how the drug affects stress hormones and metabolism, which may help you drink less and lose weight.
This trial tests if a once-weekly diabetes medication (semaglutide) can help people with HIV reduce heavy drinking and improve heart health. It's for people who drink alcohol and have a higher body weight.
This study tests whether a weekly medicine called semaglutide can help veterans who drink heavily reduce their alcohol intake. If you're a veteran and want to cut down on drinking, this study may be an option.
This study tests whether a weekly injection (a GLP-1 medication similar to semaglutide) can help people with obesity and fatty liver reduce their alcohol intake and improve liver health. It may be an option if you drink more than moderate amounts and have fatty liver.
This trial studies whether semaglutide (a diabetes-type weight-loss injection) helps adults with HIV lose weight. It also checks that it’s safe for people whose HIV is well controlled on regular treatment.
This trial tests if semaglutide (a medicine used for diabetes and weight loss) can help reduce methamphetamine use. If you qualify, you might get the study drug and support to help you cut back or stop using methamphetamine.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.